For  Immediate  Release
NACDS Welcomes CMS’ Move on MTM, Pushes for Improved Medication Use to Benefit Patient Care

Flu season can definitely be considered a corporate concern.

--an article in The Huffinton Post on how the flu affects the bottom line

Want to connect with other like-minded professionals in advancing pro-pharmacy, pro-patient priorities on Capitol Hill?
Stand Up for Pharmacy!
Improve Medication Adherence: Be the Media – Tell the Story

The Sunday, September 5 edition of The Washington Post included an article about ongoing efforts to improve medication adherence through research and patient-focused strategies.  

Read More...

Hillary Clinton Unveils Plan to Lower Drug Costs

The Story: On Tuesday, Democratic presidential nominee Hillary Clinton rolled out a plan to lower prescription drug prices. The plan switches the debate from the Affordable Care Act and focuses more on middle class concerns surrounding the rising price of medications.

Read More...

Colin Brainard joined NACDS on September 21 as the new director of federal government affairs. Prior to joining NACDS, Brainard served as a senior policy advisor for U.S. Rep. Lynn Jenkins (R-KS), who is a member of the House Ways and Means Committee, which has jurisdiction over key pharmacy issues.
Health Policy Expert Colin Brainard Joins NACDS
CDC Says 2015-2016 Flu Vaccine Should Be More Effective

Now that flu season is approaching, health experts held a news conference in Washington, D.C., stating that this year’s vaccine has been updated and should do a much better job at fighting the flu than last season’s.

Read More...

Generation Z takes in information instantaneously...and loses interest just as fast.

--a New York Times article on the challenges of marketing to Generation Z, born between 1996-2011

For  Immediate  Release
NACDS Announces Colin Brainard as Director, Federal Government Affairs
For  Immediate  Release
House Committee OK’s Reversal of Ban on OTCs in Health Savings Accounts
For  Immediate  Release
NACDS Announces Jason Ausili as Director, Pharmacy Affairs
e-Prescribing Controlled Substances Now Legal Nationwide

The Story: Following a protracted battle, on September 15 Vermont became the final state to allow e-prescribing for all controlled substances, including Schedule II painkillers such as oxycodone, hydrocodone and morphine. This is an important step forward in the fight against prescription fraud and drug abuse.

Read More...

For  Immediate  Release
NACDS Named One of the Nation's “Best Workplaces for Commuters”

The Pharmacy and Medically Underserved Areas Enhancement Act would take our healthcare system to the next level...

--Steven C. Anderson, IOM, CAE, in an op-ed in Colorado's The Daily Sentinel

New research on the effects of prescription drugs on improved patient outcomes and reduced costs in the Medicaid program was published in Health Affairs this week. The study, coauthored by NACDS Senior Economist Laura Miller (right), M. Christopher Roebuck, president and CEO of RxEconomics LLC, (center), and J. Samantha Dougherty, senior director for policy and research at Pharmaceutical Research and Manufacturers of America, (left) was presented at a special briefing non-communicable diseases in Washington, D.C., on September 9. Photo: Health Affairs
New NACDS/PhRMA Research in Health Affairs Shows Reduced Medicaid Costs